基本信息
views: 24

Bio
Clinical trials that are currently enrolling patients include a study investigating lower doses of radiation therapy for patients with diffuse large B-cell lymphoma, with the goal of maintaining excellent tumor control but decreasing the risk of long-term side effects of treatment.
Research Interests
Papers共 263 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
International journal of radiation oncology, biology, physics (2025)
Pranalee Patel, Zihan Wan, Mairead Dillon,Donna Niedzwiecki, Kerri-Anne Crowell,Mitchell E Horwitz, Edina Wang,Chris R Kelsey
M. Oertel,D. Goerlich,V. R. Sim, S. Morris, A. Hashmi, M. Levis,C. R. Kelsey,C. R. Weil,M. Chelius,C. Hague,D. E. Roos, Y. Kirova, R. Fietkau,P. Fang, A. K. Ng,Y. D. Tseng,S. A. Terezakis,R. T. Hoppe,H. T. Eich
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSno. 2 (2024): S65-S66
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSno. 2 (2024): S90-S90
Advances in Radiation Oncologyno. 5 (2024): 101450-101450
International Journal of Radiation OncologyBiologyPhysics (2024)
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSno. 2 (2024): S178-S179
Yolanda D. Tseng,Phil Stevenson, Bachviet Nguyen, Davey C. Li,Daniel Lee,Ima Paydar, Justyn Nakashima,Alex Balogh, Revathi Ravella,Andrew B Barbour,Carl Post,Hazim Ababneh,Chelsea C. Pinnix,Leslie K Ballas,Michael S Binkley,Katerina Dedeckova,Richard T Hoppe,Chirayu Patel,Nima Nabavizadeh,Christopher R. Kelsey
International Journal of Radiation OncologyBiologyPhysics (2024)
Load More
Author Statistics
#Papers: 263
#Citation: 5791
H-Index: 43
G-Index: 70
Sociability: 7
Diversity: 3
Activity: 27
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn